Navigation Links
The Prix Galien USA Awards Committee Selects Professor Mary-Claire King as 2015 Pro Bono Humanum Honoree

NEW YORK, June 25, 2015 /PRNewswire/ -- The Galien Awards Committee announced today that Mary-Claire King, Professor of Genome Sciences and Medical Genetics at the University of Washington and renowned geneticist, will receive the 2015 Pro Bono Humanum Award at the ninth annual Prix Galien USA Awards ceremony.


The Pro Bono Humanum Award recognizes ground-breaking efforts in improving human health. Professor King is the first woman recipient of the award.  

The Galien Awards Committee selected Professor Mary-Claire King in recognition of her work in transforming the application of human genetics to medicine through identification of the first gene, BRCA1, responsible for inherited susceptibility to breast cancer.  Professor King also demonstrated that the genomes of humans and chimpanzees are 99% identical, and pioneered the application of genetic sequencing in forensics to identify victims of human rights abuse.

This prestigious award, first bestowed on Dr. P. Roy Vagelos in 2007, will be presented at the American Museum of Natural History in New York City on October 27, 2015, by Professor Marc Tessier-Lavigne, Ph.D., President of The Rockefeller University and Head of the Laboratory of Brain Development and Repair.

"Professor King's work in the application of human genetics to medicine and her discovery of BRCA1, the so-called breast cancer gene, has been truly transformational in the diagnosis and treatment of the disease," said Dr. P. Roy Vagelos, Chairman of the Committee. "We are proud to name Professor King recipient of the 2015 Pro Bono Humanum Award for her unwavering dedication to improving women's health around the world."

Previous recipients of the Pro Bono Humanum Award include:

Dr. Bernard Kouchner (2014),
Dr. Anthony S. Fauci (2013),
Dr. Francis S. Collins (2012),
Pr. Paul Farmer (2011),
President Bill Clinton and Dr. Philippe Douste-Blazy (2010),
Pr. Barry Bloom and Pr. Jeffrey Sachs (2009),
Dr. Sheldon Segal and the Population Council (2008),
Dr. P. Roy Vagelos (2007)

About the Galien Foundation

The Galien Foundation fosters, recognizes and rewards excellence in scientific innovation to improve the state of human health. Our vision is to be the catalyst for the development of the next generation of innovative treatment and technologies that will impact human health and save lives.

The Foundation oversees and directs activities in the USA for the Prix Galien, an international award that recognizes outstanding achievements in improving the human condition through the development of innovative therapies. The Prix Galien was created in 1970 by Roland Mehl in honor of Galen, the father of medical science and modern pharmacology. Worldwide, the Prix Galien is regarded as the equivalent of the Nobel Prize in biopharmaceutical research.

Those interested in attending the Prix Galien USA Awards ceremony, as well as the Galien Forum, an event prior to the awards that features roundtable debates focusing on critical, global healthcare issues and challenges, can register here:

For more information visit

Galien Foundation Media Contact:

Lee A. Davies

Logo -

SOURCE Galien Foundation
Copyright©2015 PR Newswire.
All rights reserved

Related biology technology :

1. Galien Foundation Appoints Kimberly Ha of Infinata’s BioPharm Insight to US Advisory Board
2. The Galien Foundation Celebrates Biomedical Innovation in Fourth Galien Forum
3. The Galien Foundation Honors Excellence in Scientific Innovation and Humanitarian Efforts at 2013 Prix Galien USA Awards Gala
4. USP Global Fellowship Awards Program Call for Applications
5. US Radiopharmaceuticals (USR) Awards Contract to Von Gahlen International for New Technetium-99m Generator Production Line Using Low Enriched Uranium Molybdenum-99
6. American Federation for Aging Research Announces Recipients of Irving S. Wright and Vincent Cristofalo Scientific Awards
7. Elsevier and the Belarus Ministry of Education Honor Researchers with Scopus Awards
8. Bio-IT World Announces Best of Show Awards Finalists for the Bio-IT World Conference & Expo
9. BRAVE Awards Now Accepting Nominations
10. Nominierungen für BRAVE Awards werden ab jetzt entgegengenommen
11. Pfenex Inc. Awards Glide Pharma Development Contract for a Solid Formulation of Recombinant Anthrax Vaccine
Post Your Comments:
(Date:10/11/2017)... ... 11, 2017 , ... A new study published in Fertility ... fresh in vitro fertilization (IVF) transfer cycles. The multi-center matched cohort ... After comparing the results from the fresh and frozen transfer cohorts, the authors ...
(Date:10/10/2017)... ... October 10, 2017 , ... ... antibody-drug conjugate (ADC) therapeutics, today confirmed licensing rights that give it exclusive ... a technology developed in collaboration with Children’s Hospital Los Angeles (CHLA). ...
(Date:10/10/2017)... research firm Parks Associates announced today that Tom Kerber ... Annual Meeting , October 11 in Scottsdale, Arizona . ... how smart safety and security products impact the competitive landscape. ... Parks Associates: Smart Home Devices: Main Purchase Driver ... "The residential security market has experienced continued growth, and the ...
(Date:10/10/2017)... PITTSBURGH, PA (PRWEB) , ... October 10, 2017 ... ... this year’s recipients of 13 prestigious awards honoring scientists who ... be presented in a scheduled symposium during Pittcon 2018, the world’s leading conference ...
Breaking Biology Technology:
(Date:4/11/2017)... 11, 2017 NXT-ID, Inc. (NASDAQ:   ... announces the appointment of independent Directors Mr. Robin D. ... Board of Directors, furthering the company,s corporate governance and expertise. ... Gino Pereira , ... forward to their guidance and benefiting from their considerable expertise ...
(Date:4/5/2017)... Today HYPR Corp. , leading innovator ... of the HYPR platform is officially FIDO® Certified ... architecture that empowers biometric authentication across Fortune 500 enterprises ... over 15 million users across the financial services industry, ... product suites and physical access represent a growing portion ...
(Date:4/3/2017)... , April 3, 2017  Data ... precision engineering platform, detected a statistically significant ... product prior to treatment and objective response ... the potential to predict whether cancer patients ... to treatment, as well as to improve ...
Breaking Biology News(10 mins):